Monday, November 23, 2009

Will Obamacare kill medical innovation worldwide?

Interesting points here.

There's no way to argue that new drugs are not horrendously expensive. One reason is that government regulations have changed the way new drugs are priced, pushing the prices up even higher than they would have been in the "old days", by requiring drug companies to recoup their investment costs over a shorter time period, and discouraging them from charging a little more for old drugs to even out costs of the new ones. All those 4 dollar monthly prescriptions of generics from Walmart keep innovators from charging $8.00 for the drug they developed earlier, allowing them to charge less for the new ones.

And since Obamacare would control remuneration to drug and device companies and health care professionals, why not first institute wage controls for attorneys? There's a better constitutional case for providing equality in legal representation than for equality in medical care.

What would the world be like if people were only allowed to make "real money" on things that people don't really need - like, say, entertainment? Would Al Gore still be poised to make billions on the investments he has made in "green technology"?

No comments: